It looks like you're new here. If you want to get involved, click one of these buttons!
There are many imperfections/flaws that have existed for years and years with M*. Their "evaluations", star ratings, categorization, etc. became virtually useless to me. About the only things I found useful were their data on funds, and their portfolio watchlists, where I could compare selected funds using selected data measures. I focused on TR performance measures, and risk management measures. I was only interested funds that met my "momentum" criteria, with a risk adjusted measure I chose. When M* quits allowing the free access to the watchlists and data components, it appers I will be forced to consider paying them a subscription fee, which I have NOT done in years--I have not decided i I think it is worth paying them a subscription fee with the many warts that exist with M*.Morningstar Legacy Portf. Mngr:
I can still see it. I got it back after trying a couple of steps, a week or so ago. As was mentioned here at MFO, apparently, M* was doing something internally, and I was involuntarily logged out. On a logged-out basis, the default switched to the "Investor" flavor. I much prefer Legacy to the "new and improved" "Investor" version.
But bear in mind, everyone: numbers at M* get updated when they feel like doing it. And it must be asked, whether or not the updates are even accurate.
Example:
In X-Ray, I'm looking at some ridiculous discrepancies, when compared to the chart display:
X-Ray says BHB is down YTD by -25.16%. The chart shows -15.54.
NHYDY X-Ray = down -16.41. Chart shows -15.37.
ET on X-Ray: +13%. But the chart shows +11.63.
PSTL on X-Ray: +4.1. Chart says +3.23.
When M* actually offers ACCURATE info, it is extremely useful. But it's a hit or miss proposition.
And I did not check to compare FUNDS in the same way.
Notable, sure ---- but how long did he have to hold the position to see that gain? IIRC that's been a dog stock for well over a decade and I suspect he's been underwater for most of it as their largest shareholder.
https://www.forbes.com/sites/gurufocus/2021/08/02/berkowitzs-fairholme-fund-takes-a-spade-to-largest-holding-st-joe/As a result of these promising developments [in 2021], Berkowitz commented that Charlie Munger (Trades, Portfolio) was correct when he said, “The big money is not in the buying or the selling, but in the waiting.”
Given the fact that it's now almost 80% of the FAIRX portfolio, what does Bruce do now? If he pats himself on the back and moves on, can you imagine the year-end Capital Gain distribution to look forward to? He'll probably sell it and buy FNMA, and then sit back and wait a few years.Notable, sure ---- but how long did he have to hold the position to see that gain? IIRC that's been a dog stock for well over a decade and I suspect he's been underwater for most of it as their largest shareholder.
I had an edit; The decade was 2000 to the end of 2009, not end of 2010. The results were a little different. The average income was the same but the $1m was short $37k. Still not disastrous.Using Backtest, if one started with $1m in 2000 using 50/50 SPY/VBMFX (BND was not in existence) and took all income, rebalanced yearly, one ended up with slightly over $1m in 2010 and a decent income stream (positive TR). It's all we have to foretell the future. A couple of mistakes trading in 10 years to make a good TR could have been serious.
No reinvestment and the income was about $30k per year average. I am not sure how to show the results here. Starting on 2021 is not possible for 10 years into the future.@Gary, what was the total of CG's & dividends over that time period ? I'm thinking no reinvestment took place ?
Thanks , Derf
PS Now I'm wondering how this works
out over ten years if one started in
2021
I appreciate your work for ALL of our sakes. What you say is clear, but I am unable to transfer and "translate" it to the particular details of my own situation. The numbers on the tables relate to other numbers on the tables, but none of it means anything since a starting point is impossible for me to find. I've sent you a Direct Message. I hope you don't mind. :)You're looking for Table II. That is in Pub 590B here:
https://www.irs.gov/publications/p590b#en_US_2022_publink100090290
Table I (which you can find by scrolling up from Table ii) is used for inherited IRAs. Table III (scroll down from Table II) is the "usual" RMD table.
Table III simplifies calculations for most IRAs by assuming that the beneficiary has the same age (life expectancy) as the owner. The IRS figures that if the two ages are within 10 years of each other, that's, well, close enough for government work.
But if the age difference is more than 10 years, it makes a significant difference in the joint life expectancy. Since your spouse is more than 10 years younger than you, your joint life expectancy is longer than it would be if your two ages were the same. So the number you divide your IRA balance by to get your RMD is higher. That's better (lower RMD).
If you were 73 now and your spouse were 62, then the IRS would figure your joint life expectancy as 27,2 (Table II). The "usual" table (Table III) would give a life expectancy of 26.5.
© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla